These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9536579)
1. Anticoagulant control in the first three months after mechanical heart valve replacement. Hsin M; Speight J; Cooper GJ Int J Clin Pract; 1997 Oct; 51(7):427-9. PubMed ID: 9536579 [TBL] [Abstract][Full Text] [Related]
2. Warfarin sensitivity after mechanical heart valve replacement. Rose JP; Rihn TL; Long SF Pharmacotherapy; 1998; 18(4):856-9. PubMed ID: 9692661 [TBL] [Abstract][Full Text] [Related]
3. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP). Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S; Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186 [TBL] [Abstract][Full Text] [Related]
4. In-patient international normalized ratio self-testing instruction after mechanical heart valve implantation. Thompson JL; Sundt TM; Sarano ME; Santrach PJ; Schaff HV Ann Thorac Surg; 2008 Jun; 85(6):2046-50. PubMed ID: 18498817 [TBL] [Abstract][Full Text] [Related]
5. Increased sensitivity to warfarin after heart valve replacement. Rahman M; BinEsmael TM; Payne N; Butchart EG Ann Pharmacother; 2006 Mar; 40(3):397-401. PubMed ID: 16507614 [TBL] [Abstract][Full Text] [Related]
7. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Koertke H; Zittermann A; Minami K; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Morshuis M; Koerfer J; Seifert D; Koerfer R Ann Thorac Surg; 2005 Jun; 79(6):1909-14; discussion 1914. PubMed ID: 15919283 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of the switch from a branded to a generic warfarin sodium product: an observer-blinded, randomized, crossover study. Lee HL; Kan CD; Yang YJ Clin Ther; 2005 Mar; 27(3):309-19. PubMed ID: 15878384 [TBL] [Abstract][Full Text] [Related]
9. [Clinical application of anticoagulation treatment with warfarin after prosthetic heart valve replacement: a single center-based survey]. Liu Y; Yu XY; Zhong SL; Yang M; Tan HH; Fei HW; Chen JY Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2242-5. PubMed ID: 20965814 [TBL] [Abstract][Full Text] [Related]
10. Decreasing warfarin sensitivity during the first three months after heart valve surgery: implications for dosing. Meijer K; Kim YK; Schulman S Thromb Res; 2010 Mar; 125(3):224-9. PubMed ID: 19336266 [TBL] [Abstract][Full Text] [Related]
11. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing. Thompson JL; Burkhart HM; Daly RC; Dearani JA; Joyce LD; Suri RM; Schaff HV J Thorac Cardiovasc Surg; 2013 Sep; 146(3):599-604. PubMed ID: 22921821 [TBL] [Abstract][Full Text] [Related]
12. [Optimum anticoagulation control after bileaflet mechanical valve replacement: a prospective multi-institutional study]. Kitamura M; Koyanagi H; Kawada S; Hosoda Y; Kurosawa H; Takeuchi Y; Kawase M; Wanibuchi Y Kyobu Geka; 1999 Nov; 52(12):1001-4. PubMed ID: 10554485 [TBL] [Abstract][Full Text] [Related]
13. Coagulant activity during one year after bioprosthetic aortic valve replacement. Imagawa H; Ryugo M; Shikata F; Nakata T; Nagashima M; Kawachi K Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):417-20. PubMed ID: 19141491 [TBL] [Abstract][Full Text] [Related]
14. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study. Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA; Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves. Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406 [TBL] [Abstract][Full Text] [Related]
16. Study on warfarin plasma concentration and its correlation with international normalized ratio. Sun S; Wang M; Su L; Li J; Li H; Gu D J Pharm Biomed Anal; 2006 Sep; 42(2):218-22. PubMed ID: 16860509 [TBL] [Abstract][Full Text] [Related]
17. Mitral valve replacement with St. Jude Medical prosthesis and low-dose anticoagulation in patients aged over 50 years. Katircioglu SF; Yamak B; Ulus AT; Tasdemir O; Bayazit K J Heart Valve Dis; 1998 Jul; 7(4):455-9. PubMed ID: 9697071 [TBL] [Abstract][Full Text] [Related]
18. Late incidence and determinants of stroke after aortic and mitral valve replacement. Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407 [TBL] [Abstract][Full Text] [Related]
19. [Anticoagulation in chinese patients with carbomedics mechanical prosthetic heart valves]. Zhuang W; Zhou XM; Hu JG; Li JM; Yu JF; Jiang L; Hu DX Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):460-2. PubMed ID: 16134606 [TBL] [Abstract][Full Text] [Related]
20. Anticoagulant therapy after prosthetic valve replacement -optimal PT-INR in Japanese patients-. Mori T; Asano M; Ohtake H; Bitoh A; Sekiguchi S; Matsuo Y; Aiba M; Yamada M; Kawada T; Takaba T Ann Thorac Cardiovasc Surg; 2002 Apr; 8(2):83-7. PubMed ID: 12027793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]